"Mit dem Rems-Murr-Klinikum in Winnenden und der Rems-Murr-Klinik Schorndorf leisten wir eine qualifizierte Zentral- und Regelversorgung für die Menschen im Rems-Murr-Kreis und darüber hinaus. In 20 Fachkliniken mit insgesamt 915 Planbetten werden jährlich rund 50.000 Patienten stationär versorgt."

During the past decade, Rems-Murr-Klinikum Winnenden conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rems-Murr-Klinikum Winnenden" #1 sponsor was "Technische Universität Dresden" with 5 trials, followed by "University of Jena" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rems-Murr-Klinikum Winnenden" #1 collaborator was "Novartis Pharmaceuticals" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Agaplesion Kliniken Kassel" with 1 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator and "Klinikum Ludwigsburg" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Rems-Murr-Klinikum Winnenden" are "Acute Myeloid Leukemia" (2 trials), "Acute Myeloid Leukemia (AML)" (1 trials), "Atrial Fibrillation" (1 trials), "Brain Ischemia With Non-valvular Atrial Fibrillation" (1 trials) and "Chronic Heart Failure" (1 trials). Many other conditions were trialed in "Rems-Murr-Klinikum Winnenden" in a lesser frequency.

Most popular intervention types in "Rems-Murr-Klinikum Winnenden" are "Drug" (8 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "5-FU" (1 trials), "ABSORB Scaffold" (1 trials), "BAT" (1 trials), "Bevacizumab" (1 trials) and "CRT-D implantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rems-Murr-Klinikum Winnenden" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Rems-Murr-Klinikum Winnenden". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Rems-Murr-Klinikum Winnenden, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rems-Murr-Klinikum Winnenden, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".